Bleeding and Coagulopathy
Anemia is not an uncommon finding in patients with malignancy, and the etiology is often multifactorial. In patients with hematologic malignancies, anemia is usually due to the lack of production of red blood cells, rather than blood loss, but it may be due to both. In patients with solid tumors, the anemia is usually that of chronic disease, a state of impaired iron utilization and therefore decreased blood production.1–3
KeywordsHuman Leukocyte Antigen Acute Leukemia Disseminate Intravascular Coagulation Disseminate Intravascular Coagulation Platelet Transfusion
Unable to display preview. Download preview PDF.
- 6.Schiffer CA, Aisner J: Platelet and granulocyte transfusion therapy for patients with cancer, Petz LD, Swisher SN (eds): Clinical Practice of Blood Transfusion. New York, Churchill Livingstone, 1981, pp 551–572.Google Scholar
- 7.Schiffer CA, Aisner J, Daly PA: Platelet transfusion for thrombocytopenic cancer patients, Klastersky J, Staquet MJ (eds): Medical Complications in Cancer Patients. New York, Raven Press, 1981, pp 37–49.Google Scholar
- 9.Halohan TV, Terasaki PH, Deisseroth AB: Suppression of transfusion-related alloimmunization in intensively treated cancer patients. Blood 58: 122–128, 1981.Google Scholar
- 13.Sack GM, Levin J, Bell WR: Trousseau’s syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: Clinical, pathophysiologic and therapeutic features. Medicine (Baltimore) 56: 1–37, 1977.Google Scholar